The American Journal of Managed Care8h
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Gene 'silencer' in junk DNA prevents fatal neurological disease
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...
Alaskan Bush People star Ami Brown hospitalized for severe breathing issues
Ami Brown, the matriarch of the reality television series Alaskan Bush People, was recently hospitalized due to chest pains ...
The exceptionally rare disease that causes holes to form in your brain
Creutzfeldt-Jakob disease is an extremely rare and fatal brain-wasting disease that's like a human version of "mad cow." ...
The Harvard Crimson1d
HMS Research Identifies Metabolic Enzyme that Facilitates Lung Cancer Growth
Researchers at the Harvard Medical School discovered that the enzyme GUK1 promotes lung cancer growth by boosting the ...
The Lancet1d
Patient with cystic fibrosis not diagnosed until age 23 years now treated with the new triple therapy Trikafta
The effect of cystic fibrosis on many organs and the frequent lung infections means that it is mostly diagnosed in childhood. Somehow, for Verônica Stasiak Bednarczuk, that diagnosis did not arrive ...
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
Topline data from FIBRONEERâ„¢-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
Harvard Medical School6d
Research Pinpoints Weakness in Lung Cancer’s Defenses
Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...